Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
Want to see JP:4531 full AI Analyst Report?
4531 Stock Chart & Stats
¥317.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥317.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥256.00 - ¥640.00
Previous CloseN/A
Volume43.40K
Average Volume (3M)39.67K
Market Cap
¥7.77B
Enterprise Value¥13.52B
Total Cash (Recent Filing)¥1.05B
Total Debt (Recent Filing)¥9.06B
Price to Earnings (P/E)24.6
Beta0.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.97%
Share Statistics
EPS (TTM)N/A
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio-0.41
Price to Book (P/B)0.62
Price to Sales (P/S)0.55
P/FCF Ratio4.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Solid Balance SheetEquity remaining above total debt and historically moderate leverage provide a durable solvency buffer. This supports the company's ability to fund working capital and withstand industry cyclicality, preserving strategic optionality for investments or customer support over months.
Improved 2026 Cash GenerationA clear shift to strong operating cash flow and positive free cash flow in 2026 strengthens internal funding capacity. If sustained, this reduces reliance on external financing, enables reinvestment in specialty production, and improves resilience to demand swings over the medium term.
Specialty Products And Long-term CustomersThe company’s focus on specialty chemicals, tailored solutions and long-term supply agreements creates durable customer lock-in and value-added service advantages. This supports steadier demand, pricing power and higher switching costs across pharma, agriculture and industrial end markets.
Bears Say
Sharp 2026 Earnings DeclineA pronounced earnings step-down in 2026 signals margin pressure or one-off impacts that materially reduce internally available capital. If earnings remain depressed, the company’s ability to fund R&D, maintain dividends or absorb cost shocks will be constrained over the coming quarters.
Inconsistent Cash Generation HistoryMulti-year negative free cash flow through 2023–2025 indicates prior reliance on external funding or asset sales. That historical volatility reduces confidence that the 2026 cash improvement is structural, leaving funding and investment plans vulnerable if operating cash slips again.
Rising Debt And Elevated LeverageHigher absolute debt and increased leverage raise fixed interest obligations and financial rigidity. Combined with volatile earnings and uneven cash flow, elevated leverage could limit strategic flexibility and increase refinancing or liquidity risk if industry conditions deteriorate.
Yuki Gosei Kogyo Co., Ltd. News
4531 FAQ
What was Yuki Gosei Kogyo Co., Ltd.’s price range in the past 12 months?
Yuki Gosei Kogyo Co., Ltd. lowest stock price was ¥256.00 and its highest was ¥640.00 in the past 12 months.
What is Yuki Gosei Kogyo Co., Ltd.’s market cap?
Yuki Gosei Kogyo Co., Ltd.’s market cap is ¥7.77B.
When is Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Yuki Gosei Kogyo Co., Ltd.’s earnings last quarter?
Currently, no data Available
Is Yuki Gosei Kogyo Co., Ltd. overvalued?
According to Wall Street analysts Yuki Gosei Kogyo Co., Ltd.’s price is currently Overvalued.
Does Yuki Gosei Kogyo Co., Ltd. pay dividends?
Yuki Gosei Kogyo Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.97%. See more information on Yuki Gosei Kogyo Co., Ltd. dividends here
What is Yuki Gosei Kogyo Co., Ltd.’s EPS estimate?
Yuki Gosei Kogyo Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yuki Gosei Kogyo Co., Ltd. have?
Yuki Gosei Kogyo Co., Ltd. has 21,974,000 shares outstanding.
What happened to Yuki Gosei Kogyo Co., Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Yuki Gosei Kogyo Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4531
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
Technical Analysis
NANKAI CHEMICAL COMPANY LIMITED
―
Nippon Soda Co., Ltd.
―
Toho Acetylene Co., Ltd.
―
Daito Chemix Corporation
―
Toyo Gosei Co., Ltd.
―